Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the CAR T-Cell Immunotherapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
AbbVie
Pfizer
Gilead
Mustang Bio
Aurora Biopharma
Adaptimmune
Creative Biolabs
Ziopharm Oncology
Xyphos
CARsgen Therapeutics
Celgene
Kite Pharma
Bellicum
Oxford BioMedica
By Type:
Monotherapy
Combination Therapy
By Application:
Solid Malignancies
Hematologic Malignancies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China CAR T-Cell Immunotherapy Market Overview 2018-2029
-
1.1 China CAR T-Cell Immunotherapy Industry Development Overview
-
1.2 China CAR T-Cell Immunotherapy Industry Development History
-
1.3 China CAR T-Cell Immunotherapy Industry Market Size (2018-2029)
-
1.4 China CAR T-Cell Immunotherapy Market Analysis by Type from Production Side
-
1.4.1 China CAR T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of Monotherapy (2018-2029)
-
1.4.2 China CAR T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of Combination Therapy (2018-2029)
-
1.5 China CAR T-Cell Immunotherapy Market Analysis by Application from Consumption End
-
1.5.1 China CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Solid Malignancies (2018-2029)
-
1.5.2 China CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Hematologic Malignancies (2018-2029)
-
1.6 China CAR T-Cell Immunotherapy Market Analysis by Region
-
1.6.1 North China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
1.6.3 South China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
1.6.4 East China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
Chapter 2 China CAR T-Cell Immunotherapy Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on CAR T-Cell Immunotherapy Market Status and Competition at home and abroad in 2023
-
2.2.2 China CAR T-Cell Immunotherapy Market Status and Competition Analysis in 2023
-
2.2.3 China CAR T-Cell Immunotherapy Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China CAR T-Cell Immunotherapy Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on CAR T-Cell Immunotherapy Industry Development
Chapter 3 CAR T-Cell ImmunotherapyIndustry Chain Analysis
-
3.1 CAR T-Cell Immunotherapy Industry Chain
-
3.2 CAR T-Cell Immunotherapy Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the CAR T-Cell Immunotherapy Market
-
3.3 CAR T-Cell Immunotherapy Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the CAR T-Cell Immunotherapy Market
Chapter 4 China CAR T-Cell Immunotherapy Market, by Type
-
4.1 China CAR T-Cell Immunotherapy Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China CAR T-Cell Immunotherapy Total Production Volume and Growth Rate from Production Side
-
4.5 China CAR T-Cell Immunotherapy Production Volume and Growth Rate, by Type
-
4.5.1 China CAR T-Cell Immunotherapy Production Volume and Growth Rate of Monotherapy
-
4.5.2 China CAR T-Cell Immunotherapy Production Volume and Growth Rate of Combination Therapy
Chapter 5 China CAR T-Cell Immunotherapy Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China CAR T-Cell Immunotherapy Total Market Size and Growth Rate from Consumption End
-
5.5 China CAR T-Cell Immunotherapy Market Size and Growth Rate, by Application
-
5.5.1 China CAR T-Cell Immunotherapy Market Size and Growth Rate of Solid Malignancies
-
5.5.2 China CAR T-Cell Immunotherapy Market Size and Growth Rate of Hematologic Malignancies
Chapter 6 China CAR T-Cell Immunotherapy Market, by Region
-
6.1 China CAR T-Cell Immunotherapy Production Volume and Production Value, by Region
-
6.2 China CAR T-Cell Immunotherapy Sales Volume and Sales Value, by Region
Chapter 7 North China CAR T-Cell Immunotherapy Market Analysis
-
7.1 North China CAR T-Cell Immunotherapy Market, by Type
-
7.2 North China CAR T-Cell Immunotherapy Market, by Application
Chapter 8 Central China CAR T-Cell Immunotherapy Market Analysis
-
8.1 Central China CAR T-Cell Immunotherapy Market, by Type
-
8.2 Central China CAR T-Cell Immunotherapy Market, by Application
Chapter 9 South China CAR T-Cell Immunotherapy Market Analysis
-
9.1 South China CAR T-Cell Immunotherapy Market, by Type
-
9.2 South China CAR T-Cell Immunotherapy Market, by Application
Chapter 10 East China CAR T-Cell Immunotherapy Market Analysis
-
10.1 East China CAR T-Cell Immunotherapy Market, by Type
-
10.2 East China CAR T-Cell Immunotherapy Market, by Application
Chapter 11 Northeast China CAR T-Cell Immunotherapy Market Analysis
-
11.1 Northeast China CAR T-Cell Immunotherapy Market, by Type
-
11.2 Northeast China CAR T-Cell Immunotherapy Market, by Application
Chapter 12 Southwest China CAR T-Cell Immunotherapy Market Analysis
-
12.1 Southwest China CAR T-Cell Immunotherapy Market, by Type
-
12.2 Southwest China CAR T-Cell Immunotherapy Market, by Application
Chapter 13 Northwest China CAR T-Cell Immunotherapy Market Analysis
-
13.1 Northwest China CAR T-Cell Immunotherapy Market, by Type
-
13.2 Northwest China CAR T-Cell Immunotherapy Market, by Application
Chapter 14 Company Profiles
-
14.1 AbbVie
-
14.1.1 AbbVie Company Profile
-
14.1.2 AbbVie CAR T-Cell Immunotherapy Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Pfizer
-
14.2.1 Pfizer Company Profile
-
14.2.2 Pfizer CAR T-Cell Immunotherapy Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Gilead
-
14.3.1 Gilead Company Profile
-
14.3.2 Gilead CAR T-Cell Immunotherapy Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Mustang Bio
-
14.4.1 Mustang Bio Company Profile
-
14.4.2 Mustang Bio CAR T-Cell Immunotherapy Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Aurora Biopharma
-
14.5.1 Aurora Biopharma Company Profile
-
14.5.2 Aurora Biopharma CAR T-Cell Immunotherapy Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Adaptimmune
-
14.6.1 Adaptimmune Company Profile
-
14.6.2 Adaptimmune CAR T-Cell Immunotherapy Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Creative Biolabs
-
14.7.1 Creative Biolabs Company Profile
-
14.7.2 Creative Biolabs CAR T-Cell Immunotherapy Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Ziopharm Oncology
-
14.8.1 Ziopharm Oncology Company Profile
-
14.8.2 Ziopharm Oncology CAR T-Cell Immunotherapy Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Xyphos
-
14.9.1 Xyphos Company Profile
-
14.9.2 Xyphos CAR T-Cell Immunotherapy Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 CARsgen Therapeutics
-
14.10.1 CARsgen Therapeutics Company Profile
-
14.10.2 CARsgen Therapeutics CAR T-Cell Immunotherapy Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Celgene
-
14.11.1 Celgene Company Profile
-
14.11.2 Celgene CAR T-Cell Immunotherapy Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Kite Pharma
-
14.12.1 Kite Pharma Company Profile
-
14.12.2 Kite Pharma CAR T-Cell Immunotherapy Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Bellicum
-
14.13.1 Bellicum Company Profile
-
14.13.2 Bellicum CAR T-Cell Immunotherapy Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Oxford BioMedica
-
14.14.1 Oxford BioMedica Company Profile
-
14.14.2 Oxford BioMedica CAR T-Cell Immunotherapy Market Performance
-
14.14.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 CAR T-Cell Immunotherapy Industry Research Conclusions
-
15.2 CAR T-Cell Immunotherapy Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China CAR T-Cell Immunotherapy Industry Market Size (2018-2029)
-
Figure China CAR T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of Monotherapy (2018-2029)
-
Figure China CAR T-Cell Immunotherapy Production Volume, Production Value and Growth Rate of Combination Therapy (2018-2029)
-
Figure China CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Solid Malignancies (2018-2029)
-
Figure China CAR T-Cell Immunotherapy Sales Volume, Sales Value and Growth Rate of Hematologic Malignancies (2018-2029)
-
Figure North China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
Figure Central China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
Figure South China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
Figure East China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
Figure Northeast China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
Figure Southwest China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
Figure Northwest China CAR T-Cell Immunotherapy Market Size and Growth Rate from 2018-2029
-
Figure CAR T-Cell Immunotherapy Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China CAR T-Cell Immunotherapy Market Share by Type in 2018
-
Figure China CAR T-Cell Immunotherapy Market Share by Type in 2023
-
Figure China CAR T-Cell Immunotherapy Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China CAR T-Cell Immunotherapy Production Volume and Growth Rate of Monotherapy (2018-2023)
-
Figure China CAR T-Cell Immunotherapy Production Volume and Growth Rate of Combination Therapy (2018-2023)
-
Figure China CAR T-Cell Immunotherapy Market Share by Application in 2018
-
Figure China CAR T-Cell Immunotherapy Market Share by Application in 2023
-
Figure China CAR T-Cell Immunotherapy Total Market Size and Growth Rate from Consumption End
-
Figure China CAR T-Cell Immunotherapy Market Size and Growth Rate of Solid Malignancies (2018-2023)
-
Figure China CAR T-Cell Immunotherapy Market Size and Growth Rate of Hematologic Malignancies (2018-2023)
-
Table China CAR T-Cell Immunotherapy Production Volume by Region (2018-2023)
-
Table China CAR T-Cell Immunotherapy Production Volume Share by Region (2018-2023)
-
Figure China CAR T-Cell Immunotherapy Production Volume Share by Region (2018-2023)
-
Table China CAR T-Cell Immunotherapy Production Value by Region (2018-2023)
-
Table China CAR T-Cell Immunotherapy Production Value Share by Region (2018-2023)
-
Figure China CAR T-Cell Immunotherapy Production Value Share by Region (2018-2023)
-
Table China CAR T-Cell Immunotherapy Sales Volume by Region (2018-2023)
-
Table China CAR T-Cell Immunotherapy Sales Volume Share by Region (2018-2023)
-
Figure China CAR T-Cell Immunotherapy Sales Volume Share by Region (2018-2023)
-
Table China CAR T-Cell Immunotherapy Sales Value by Region (2018-2023)
-
Table China CAR T-Cell Immunotherapy Sales Value Share by Region (2018-2023)
-
Figure China CAR T-Cell Immunotherapy Sales Value Share by Region (2018-2023)
-
Table North China CAR T-Cell Immunotherapy Production Volume by Type (2018-2023)
-
Table North China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Figure North China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Table North China CAR T-Cell Immunotherapy Sales Volume by Application (2018-2023)
-
Table North China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Figure North China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Table Central China CAR T-Cell Immunotherapy Production Volume by Type (2018-2023)
-
Table Central China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Figure Central China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Table Central China CAR T-Cell Immunotherapy Sales Volume by Application (2018-2023)
-
Table Central China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Figure Central China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Table South China CAR T-Cell Immunotherapy Production Volume by Type (2018-2023)
-
Table South China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Figure South China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Table South China CAR T-Cell Immunotherapy Sales Volume by Application (2018-2023)
-
Table South China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Figure South China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Table East China CAR T-Cell Immunotherapy Production Volume by Type (2018-2023)
-
Table East China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Figure East China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Table East China CAR T-Cell Immunotherapy Sales Volume by Application (2018-2023)
-
Table East China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Figure East China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Table Northeast China CAR T-Cell Immunotherapy Production Volume by Type (2018-2023)
-
Table Northeast China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Figure Northeast China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Table Northeast China CAR T-Cell Immunotherapy Sales Volume by Application (2018-2023)
-
Table Northeast China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Figure Northeast China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Table Southwest China CAR T-Cell Immunotherapy Production Volume by Type (2018-2023)
-
Table Southwest China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Figure Southwest China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Table Southwest China CAR T-Cell Immunotherapy Sales Volume by Application (2018-2023)
-
Table Southwest China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Figure Southwest China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Table Northwest China CAR T-Cell Immunotherapy Production Volume by Type (2018-2023)
-
Table Northwest China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Figure Northwest China CAR T-Cell Immunotherapy Production Volume Share by Type (2018-2023)
-
Table Northwest China CAR T-Cell Immunotherapy Sales Volume by Application (2018-2023)
-
Table Northwest China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Figure Northwest China CAR T-Cell Immunotherapy Sales Volume Share by Application (2018-2023)
-
Table AbbVie Company Profile
-
Table AbbVie CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Gilead Company Profile
-
Table Gilead CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Mustang Bio Company Profile
-
Table Mustang Bio CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Aurora Biopharma Company Profile
-
Table Aurora Biopharma CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Adaptimmune Company Profile
-
Table Adaptimmune CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Creative Biolabs Company Profile
-
Table Creative Biolabs CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Ziopharm Oncology Company Profile
-
Table Ziopharm Oncology CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Xyphos Company Profile
-
Table Xyphos CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table CARsgen Therapeutics Company Profile
-
Table CARsgen Therapeutics CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Celgene Company Profile
-
Table Celgene CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Kite Pharma Company Profile
-
Table Kite Pharma CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Bellicum Company Profile
-
Table Bellicum CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
Table Oxford BioMedica Company Profile
-
Table Oxford BioMedica CAR T-Cell Immunotherapy Revenue, Price and Gross (2018-2023)
-
